Form 4: Foghorn Therapeutics Executive Fanny Cavalie Sells 11,000 Shares

Fanny Cavalie, Chief Strategy/Bus Ops Officer at Foghorn Therapeutics, sold 11,000 shares of common stock at an average price of $6.5576 on March 11, 2024.

Summary

• On March 11, 2024, Fanny Cavalie, the Chief Strategy/Bus Ops Officer of Foghorn Therapeutics Inc. (FHTX), sold 11,000 shares of the company's common stock.
• The sale was executed at a weighted average price of $6.5576 per share, with individual trades occurring between $6.50 and $6.83.
• Following the transaction, Cavalie directly owns 75,992 shares of Foghorn Therapeutics.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting a transaction. The sentiment is slightly negative as insider selling can sometimes be interpreted as a lack of confidence, but it's a routine event.

Negatives

• An executive selling shares can sometimes be perceived negatively by investors, although it doesn't necessarily indicate a negative outlook for the company.

Industry Context

Insider sales are a common occurrence in publicly traded companies and are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects.

Key Dates